Biobanking, identification of biomarkers and the study on immune system in patients with multiple sclerosis

Biobanking, identification of biomarkers and the study on immune system in patients with multiple sclerosis - MS biobank

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37545

Enrollment

2000

Registered

2013-11-07

Start date

2013-01-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Individuals must be at least 18 years old and able to give informed consent. -Individuals must have one of the diagnoses: clinically isolated syndrom, relapsing-remitting MS, primary progressive MS, secondary progressive MS, neuromyelitis optica, transverse myelitis, and radiologically isolated syndrome. -Individuals must be willing and able to provide blood and/or cerebrospinal fluid in addtion to requirement for clinical analysis

Exclusion criteria

Exclusion criteria: -Patients currently diagnosed with an autoimmune disorder other than MS. -Patients with ongoing bacterial, viral, or fungal infection.

Countries

Netherlands

Outcome results